elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30827853-316BF97B-04D7-4C4D-81C3-A0D3AD2A2816
Q30827853-316BF97B-04D7-4C4D-81C3-A0D3AD2A2816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30827853-316BF97B-04D7-4C4D-81C3-A0D3AD2A2816
Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.
P2860
Q30827853-316BF97B-04D7-4C4D-81C3-A0D3AD2A2816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30827853-316BF97B-04D7-4C4D-81C3-A0D3AD2A2816
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
387fd7fcba4c1d237a54cde4030e837eb1a85223
P2860
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial